Concurrent Taxol (Paclitaxel) and Definitive Breast Radiation Therapy in Early Stage Breast Cancer Following Four Cycles of Adriamycin/Cytoxan Chemotherapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Breast cancer
- Focus Therapeutic Use
- 29 Jan 2018 Planned End Date changed from 1 Aug 2017 to 1 Feb 2019.
- 01 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2017.
- 24 Jul 2015 Planned end changed from 1 Nov 2015 to 1Jul 2016 as reported by ClinicalTrials.gov record.